APO Research
Talk to an analyst

APO RESEARCH · REPORT

SPECT Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global SPECT Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchSPECT Radiopharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal SPECT Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal SPECT Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SPECT Radiopharmaceuticals Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal SPECT Radiopharmaceuticals Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global SPECT Radiopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for SPECT Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of SPECT Radiopharmaceuticals include Siemens Healthineers, NorthStar Medical Radioisotopes, Molecular Imaging, Inc., Lantheus Medical Imaging, IBA Molecular Imaging, GE Healthcare, Eczacibasi-Monrol, Curium Pharma and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global SPECT Radiopharmaceuticals market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of SPECT Radiopharmaceuticals and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SPECT Radiopharmaceuticals revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the SPECT Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

SPECT Radiopharmaceuticals Segment by Company

Siemens Healthineers

NorthStar Medical Radioisotopes

Molecular Imaging, Inc.

Lantheus Medical Imaging

IBA Molecular Imaging

GE Healthcare

Eczacibasi-Monrol

Curium Pharma

Cardinal Health

Bracco Imaging

Bayer (Radiology Division)

Advanced Accelerator Applications

SPECT Radiopharmaceuticals Segment by Type

Indium-111 (In-111) Based Agents

Thallium-201 (Tl-201)

Gallium-67 (Ga-67)

Iodine-123 (I-123) Based Agents

Technetium-99m (Tc-99m) Based Agents

SPECT Radiopharmaceuticals Segment by Application

Cardiac Imaging

Brain Imaging

Thyroid Imaging

Infection and Inflammation Imaging

Cancer Imaging

SPECT Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SPECT Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SPECT Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SPECT Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of SPECT Radiopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global SPECT Radiopharmaceuticals industry.

Chapter 3: Detailed analysis of SPECT Radiopharmaceuticals companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, SPECT Radiopharmaceuticalsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Indium-111 (In-111) Based Agents Table 3. Key Players of Thallium-201 (Tl-201) Table 4. Key Players of Gallium-67 (Ga-67) Table 3. Key Players of Iodine-123 (I-123) Based Agents Table 4. Key Players of Technetium-99m (Tc-99m) Based Agents Table 5. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Cardiac Imaging Table 7. Key Players of Brain Imaging Table 8. Key Players of Thyroid Imaging Table 9. Key Players of Infection and Inflammation Imaging Table 10. Key Players of Cancer Imaging Table 11. Global SPECT Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global SPECT Radiopharmaceuticals Market Size by Region (2021-2026) & (US$ Million) Table 13. Global SPECT Radiopharmaceuticals Market Share by Region (2021-2026) Table 14. Global SPECT Radiopharmaceuticals Market Size by Region (2027-2032) & (US$ Million) Table 15. Global SPECT Radiopharmaceuticals Market Share by Region (2027-2032) Table 16. SPECT Radiopharmaceuticals Industry Trends Table 17. SPECT Radiopharmaceuticals Industry Drivers Table 18. SPECT Radiopharmaceuticals Industry Opportunities and Challenges Table 19. SPECT Radiopharmaceuticals Industry Restraints Table 20. Global SPECT Radiopharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 21. Global SPECT Radiopharmaceuticals Revenue Market Share by Company (2021-2026) Table 22. Global SPECT Radiopharmaceuticals Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global SPECT Radiopharmaceuticals Key Company Head Office and Area Served Table 24. Global SPECT Radiopharmaceuticals Company, Product Type & Application Table 25. Global SPECT Radiopharmaceuticals Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global SPECT Radiopharmaceuticals Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 30. Global SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 31. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 32. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 33. Global SPECT Radiopharmaceuticals Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 35. Global SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 36. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 37. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 38. Siemens Healthineers Company Information Table 39. Siemens Healthineers Business Overview Table 40. Siemens Healthineers SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Siemens Healthineers SPECT Radiopharmaceuticals Product Portfolio Table 42. Siemens Healthineers Recent Development Table 43. NorthStar Medical Radioisotopes Company Information Table 44. NorthStar Medical Radioisotopes Business Overview Table 45. NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Portfolio Table 47. NorthStar Medical Radioisotopes Recent Development Table 48. Molecular Imaging, Inc. Company Information Table 49. Molecular Imaging, Inc. Business Overview Table 50. Molecular Imaging, Inc. SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Portfolio Table 52. Molecular Imaging, Inc. Recent Development Table 53. Lantheus Medical Imaging Company Information Table 54. Lantheus Medical Imaging Business Overview Table 55. Lantheus Medical Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Portfolio Table 57. Lantheus Medical Imaging Recent Development Table 58. IBA Molecular Imaging Company Information Table 59. IBA Molecular Imaging Business Overview Table 60. IBA Molecular Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. IBA Molecular Imaging SPECT Radiopharmaceuticals Product Portfolio Table 62. IBA Molecular Imaging Recent Development Table 63. GE Healthcare Company Information Table 64. GE Healthcare Business Overview Table 65. GE Healthcare SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. GE Healthcare SPECT Radiopharmaceuticals Product Portfolio Table 67. GE Healthcare Recent Development Table 68. Eczacibasi-Monrol Company Information Table 69. Eczacibasi-Monrol Business Overview Table 70. Eczacibasi-Monrol SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Portfolio Table 72. Eczacibasi-Monrol Recent Development Table 73. Curium Pharma Company Information Table 74. Curium Pharma Business Overview Table 75. Curium Pharma SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Curium Pharma SPECT Radiopharmaceuticals Product Portfolio Table 77. Curium Pharma Recent Development Table 78. Cardinal Health Company Information Table 79. Cardinal Health Business Overview Table 80. Cardinal Health SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Cardinal Health SPECT Radiopharmaceuticals Product Portfolio Table 82. Cardinal Health Recent Development Table 83. Bracco Imaging Company Information Table 84. Bracco Imaging Business Overview Table 85. Bracco Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Bracco Imaging SPECT Radiopharmaceuticals Product Portfolio Table 87. Bracco Imaging Recent Development Table 88. Bayer (Radiology Division) Company Information Table 89. Bayer (Radiology Division) Business Overview Table 90. Bayer (Radiology Division) SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Portfolio Table 92. Bayer (Radiology Division) Recent Development Table 93. Advanced Accelerator Applications Company Information Table 94. Advanced Accelerator Applications Business Overview Table 95. Advanced Accelerator Applications SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Portfolio Table 97. Advanced Accelerator Applications Recent Development Table 98. North America SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 99. North America SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 100. North America SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 101. North America SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 102. North America SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America SPECT Radiopharmaceuticals Market Size by Country (2021-2026) Table 104. North America SPECT Radiopharmaceuticals Market Size by Country (2027-2032) Table 105. Europe SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 106. Europe SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 107. Europe SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 108. Europe SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 109. Europe SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe SPECT Radiopharmaceuticals Market Size by Country (2021-2026) Table 111. Europe SPECT Radiopharmaceuticals Market Size by Country (2027-2032) Table 112. China SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 113. China SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 114. China SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 115. China SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 117. Asia SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 118. Asia SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 119. Asia SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 120. Asia SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia SPECT Radiopharmaceuticals Market Size by Country (2021-2026) Table 122. Asia SPECT Radiopharmaceuticals Market Size by Country (2027-2032) Table 123. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 124. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 125. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021-2026) Table 129. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. SPECT Radiopharmaceuticals Product Image Figure 2. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global SPECT Radiopharmaceuticals Market Share by Type: 2025 VS 2032 Figure 4. Indium-111 (In-111) Based Agents Image Figure 5. Thallium-201 (Tl-201) Image Figure 6. Gallium-67 (Ga-67) Image Figure 7. Iodine-123 (I-123) Based Agents Image Figure 8. Technetium-99m (Tc-99m) Based Agents Image Figure 9. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global SPECT Radiopharmaceuticals Market Share by Application: 2025 VS 2032 Figure 11. Cardiac Imaging Image Figure 12. Brain Imaging Image Figure 13. Thyroid Imaging Image Figure 14. Infection and Inflammation Imaging Image Figure 15. Cancer Imaging Image Figure 16. Global SPECT Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 18. Global SPECT Radiopharmaceuticals Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global SPECT Radiopharmaceuticals Market Share by Players in 2025 Figure 21. Global Top 5 and 10 SPECT Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global SPECT Radiopharmaceuticals Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 25. Global SPECT Radiopharmaceuticals Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 27. North America SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 28. North America SPECT Radiopharmaceuticals Market Share by Type (2021-2032) Figure 29. North America SPECT Radiopharmaceuticals Market Share by Application (2021-2032) Figure 30. North America SPECT Radiopharmaceuticals Market Share by Country (2021-2032) Figure 31. United States SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 32. Canada SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 33. Mexico SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 34. Europe SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 35. Europe SPECT Radiopharmaceuticals Market Share by Type (2021-2032) Figure 36. Europe SPECT Radiopharmaceuticals Market Share by Application (2021-2032) Figure 37. Europe SPECT Radiopharmaceuticals Market Share by Country (2021-2032) Figure 38. Germany SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 39. France SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 40. U.K. SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 41. Italy SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 42. Russia SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 44. China SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 45. China SPECT Radiopharmaceuticals Market Share by Type (2021-2032) Figure 46. China SPECT Radiopharmaceuticals Market Share by Application (2021-2032) Figure 47. Asia SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 48. Asia SPECT Radiopharmaceuticals Market Share by Type (2021-2032) Figure 49. Asia SPECT Radiopharmaceuticals Market Share by Application (2021-2032) Figure 50. Asia SPECT Radiopharmaceuticals Market Share by Country (2021-2032) Figure 51. Japan SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 52. South Korea SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 55. India SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 56. Australia SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Country (2021-2032) Figure 61. Brazil SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 62. South Africa SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 64. Turkey SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 65. Argentina SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 66. UAE SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 67. Egypt SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 68. Chile SPECT Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Indium-111 (In-111) Based Agents
  • Thallium-201 (Tl-201)
  • Gallium-67 (Ga-67)
  • Iodine-123 (I-123) Based Agents
  • Technetium-99m (Tc-99m) Based Agents
Applications
  • Cardiac Imaging
  • Brain Imaging
  • Thyroid Imaging
  • Infection and Inflammation Imaging
  • Cancer Imaging
Companies covered
  • Siemens Healthineers
  • NorthStar Medical Radioisotopes
  • Molecular Imaging, Inc.
  • Lantheus Medical Imaging
  • IBA Molecular Imaging
  • GE Healthcare
  • Eczacibasi-Monrol
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Bayer (Radiology Division)
  • Advanced Accelerator Applications

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Indium-111 (In-111) Based Agents
  5. 1.2.3 Thallium-201 (Tl-201)
  6. 1.2.4 Gallium-67 (Ga-67)
  7. 1.2.5 Iodine-123 (I-123) Based Agents
  8. 1.2.6 Technetium-99m (Tc-99m) Based Agents
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Cardiac Imaging
  12. 1.3.3 Brain Imaging
  13. 1.3.4 Thyroid Imaging
  14. 1.3.5 Infection and Inflammation Imaging
  15. 1.3.6 Cancer Imaging
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global SPECT Radiopharmaceuticals Growth Trends by Region
  18. 1.5.1 Global SPECT Radiopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 SPECT Radiopharmaceuticals Market Size by Region (2021-2026)
  20. 1.5.3 SPECT Radiopharmaceuticals Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global SPECT Radiopharmaceuticals Market Dynamics
  1. 2.1 SPECT Radiopharmaceuticals Industry Trends
  2. 2.2 SPECT Radiopharmaceuticals Industry Drivers
  3. 2.3 SPECT Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 SPECT Radiopharmaceuticals Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global SPECT Radiopharmaceuticals Revenue by Company (2021-2026)
  2. 3.2 Global SPECT Radiopharmaceuticals Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global SPECT Radiopharmaceuticals Key Company Head office and Area Served
  4. 3.4 Global SPECT Radiopharmaceuticals Company, Product Type & Application
  5. 3.5 Global SPECT Radiopharmaceuticals Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global SPECT Radiopharmaceuticals Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 SPECT Radiopharmaceuticals Players Market Share by Revenue in 2025
  9. 3.6.3 2025 SPECT Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 SPECT Radiopharmaceuticals Market by Type
  1. 4.1 Global SPECT Radiopharmaceuticals Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global SPECT Radiopharmaceuticals Market Size by Type (2021-2032)
  3. 4.3 Global SPECT Radiopharmaceuticals Market Size Share by Type (2021-2032)
5 SPECT Radiopharmaceuticals Market by Application
  1. 5.1 Global SPECT Radiopharmaceuticals Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global SPECT Radiopharmaceuticals Market Size by Application (2021-2032)
  3. 5.3 Global SPECT Radiopharmaceuticals Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Siemens Healthineers
  2. 6.1.1 Siemens Healthineers Company Information
  3. 6.1.2 Siemens Healthineers Business Overview
  4. 6.1.3 Siemens Healthineers SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Siemens Healthineers SPECT Radiopharmaceuticals Product Portfolio
  6. 6.1.5 Siemens Healthineers Recent Developments
  7. 6.2 NorthStar Medical Radioisotopes
  8. 6.2.1 NorthStar Medical Radioisotopes Company Information
  9. 6.2.2 NorthStar Medical Radioisotopes Business Overview
  10. 6.2.3 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Portfolio
  12. 6.2.5 NorthStar Medical Radioisotopes Recent Developments
  13. 6.3 Molecular Imaging, Inc.
  14. 6.3.1 Molecular Imaging, Inc. Company Information
  15. 6.3.2 Molecular Imaging, Inc. Business Overview
  16. 6.3.3 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Portfolio
  18. 6.3.5 Molecular Imaging, Inc. Recent Developments
  19. 6.4 Lantheus Medical Imaging
  20. 6.4.1 Lantheus Medical Imaging Company Information
  21. 6.4.2 Lantheus Medical Imaging Business Overview
  22. 6.4.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Portfolio
  24. 6.4.5 Lantheus Medical Imaging Recent Developments
  25. 6.5 IBA Molecular Imaging
  26. 6.5.1 IBA Molecular Imaging Company Information
  27. 6.5.2 IBA Molecular Imaging Business Overview
  28. 6.5.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Portfolio
  30. 6.5.5 IBA Molecular Imaging Recent Developments
  31. 6.6 GE Healthcare
  32. 6.6.1 GE Healthcare Company Information
  33. 6.6.2 GE Healthcare Business Overview
  34. 6.6.3 GE Healthcare SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GE Healthcare SPECT Radiopharmaceuticals Product Portfolio
  36. 6.6.5 GE Healthcare Recent Developments
  37. 6.7 Eczacibasi-Monrol
  38. 6.7.1 Eczacibasi-Monrol Company Information
  39. 6.7.2 Eczacibasi-Monrol Business Overview
  40. 6.7.3 Eczacibasi-Monrol SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Portfolio
  42. 6.7.5 Eczacibasi-Monrol Recent Developments
  43. 6.8 Curium Pharma
  44. 6.8.1 Curium Pharma Company Information
  45. 6.8.2 Curium Pharma Business Overview
  46. 6.8.3 Curium Pharma SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Curium Pharma SPECT Radiopharmaceuticals Product Portfolio
  48. 6.8.5 Curium Pharma Recent Developments
  49. 6.9 Cardinal Health
  50. 6.9.1 Cardinal Health Company Information
  51. 6.9.2 Cardinal Health Business Overview
  52. 6.9.3 Cardinal Health SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Cardinal Health SPECT Radiopharmaceuticals Product Portfolio
  54. 6.9.5 Cardinal Health Recent Developments
  55. 6.10 Bracco Imaging
  56. 6.10.1 Bracco Imaging Company Information
  57. 6.10.2 Bracco Imaging Business Overview
  58. 6.10.3 Bracco Imaging SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bracco Imaging SPECT Radiopharmaceuticals Product Portfolio
  60. 6.10.5 Bracco Imaging Recent Developments
  61. 6.11 Bayer (Radiology Division)
  62. 6.11.1 Bayer (Radiology Division) Company Information
  63. 6.11.2 Bayer (Radiology Division) Business Overview
  64. 6.11.3 Bayer (Radiology Division) SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Portfolio
  66. 6.11.5 Bayer (Radiology Division) Recent Developments
  67. 6.12 Advanced Accelerator Applications
  68. 6.12.1 Advanced Accelerator Applications Company Information
  69. 6.12.2 Advanced Accelerator Applications Business Overview
  70. 6.12.3 Advanced Accelerator Applications SPECT Radiopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Portfolio
  72. 6.12.5 Advanced Accelerator Applications Recent Developments
7 North America
  1. 7.1 North America SPECT Radiopharmaceuticals Market Size (2021-2032)
  2. 7.2 North America SPECT Radiopharmaceuticals Market Size by Type
  3. 7.2.1 North America SPECT Radiopharmaceuticals Market Size by Type (2021-2026)
  4. 7.2.2 North America SPECT Radiopharmaceuticals Market Size by Type (2027-2032)
  5. 7.2.3 North America SPECT Radiopharmaceuticals Market Share by Type (2021-2032)
  6. 7.3 North America SPECT Radiopharmaceuticals Market Size by Application
  7. 7.3.1 North America SPECT Radiopharmaceuticals Market Size by Application (2021-2026)
  8. 7.3.2 North America SPECT Radiopharmaceuticals Market Size by Application (2027-2032)
  9. 7.3.3 North America SPECT Radiopharmaceuticals Market Share by Application (2021-2032)
  10. 7.4 North America SPECT Radiopharmaceuticals Market Size by Country
  11. 7.4.1 North America SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
  13. 7.4.3 North America SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
  14. 7.4.4 North America SPECT Radiopharmaceuticals Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe SPECT Radiopharmaceuticals Market Size (2021-2032)
  2. 8.2 Europe SPECT Radiopharmaceuticals Market Size by Type
  3. 8.2.1 Europe SPECT Radiopharmaceuticals Market Size by Type (2021-2026)
  4. 8.2.2 Europe SPECT Radiopharmaceuticals Market Size by Type (2027-2032)
  5. 8.2.3 Europe SPECT Radiopharmaceuticals Market Share by Type (2021-2032)
  6. 8.3 Europe SPECT Radiopharmaceuticals Market Size by Application
  7. 8.3.1 Europe SPECT Radiopharmaceuticals Market Size by Application (2021-2026)
  8. 8.3.2 Europe SPECT Radiopharmaceuticals Market Size by Application (2027-2032)
  9. 8.3.3 Europe SPECT Radiopharmaceuticals Market Share by Application (2021-2032)
  10. 8.4 Europe SPECT Radiopharmaceuticals Market Size by Country
  11. 8.4.1 Europe SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
  13. 8.4.3 Europe SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
  14. 8.4.4 Europe SPECT Radiopharmaceuticals Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China SPECT Radiopharmaceuticals Market Size (2021-2032)
  2. 9.2 China SPECT Radiopharmaceuticals Market Size by Type
  3. 9.2.1 China SPECT Radiopharmaceuticals Market Size by Type (2021-2026)
  4. 9.2.2 China SPECT Radiopharmaceuticals Market Size by Type (2027-2032)
  5. 9.2.3 China SPECT Radiopharmaceuticals Market Share by Type (2021-2032)
  6. 9.3 China SPECT Radiopharmaceuticals Market Size by Application
  7. 9.3.1 China SPECT Radiopharmaceuticals Market Size by Application (2021-2026)
  8. 9.3.2 China SPECT Radiopharmaceuticals Market Size by Application (2027-2032)
  9. 9.3.3 China SPECT Radiopharmaceuticals Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia SPECT Radiopharmaceuticals Market Size (2021-2032)
  2. 10.2 Asia SPECT Radiopharmaceuticals Market Size by Type
  3. 10.2.1 Asia SPECT Radiopharmaceuticals Market Size by Type (2021-2026)
  4. 10.2.2 Asia SPECT Radiopharmaceuticals Market Size by Type (2027-2032)
  5. 10.2.3 Asia SPECT Radiopharmaceuticals Market Share by Type (2021-2032)
  6. 10.3 Asia SPECT Radiopharmaceuticals Market Size by Application
  7. 10.3.1 Asia SPECT Radiopharmaceuticals Market Size by Application (2021-2026)
  8. 10.3.2 Asia SPECT Radiopharmaceuticals Market Size by Application (2027-2032)
  9. 10.3.3 Asia SPECT Radiopharmaceuticals Market Share by Application (2021-2032)
  10. 10.4 Asia SPECT Radiopharmaceuticals Market Size by Country
  11. 10.4.1 Asia SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
  13. 10.4.3 Asia SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
  14. 10.4.4 Asia SPECT Radiopharmaceuticals Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Type
  3. 11.2.1 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Application
  7. 11.3.1 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country
  11. 11.4.1 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa SPECT Radiopharmaceuticals Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst